Lynparza (olaparib) has an elimination half-life of roughly 12 hours, meaning your body clears about half the drug from your bloodstream every 12 hours. After your last dose, most of the active drug is gone within about 3 days. However, in clinical studies tracking radioactively labeled olaparib, 97% of the dose was recovered from the body within 7 days. That 7-day window is the best estimate for how long traces of the drug and its breakdown products remain in your system.
How Lynparza Leaves Your Body
Your body eliminates Lynparza through two nearly equal routes: about 44% through urine and 42% through feces. Only a small fraction leaves as the original, unchanged drug (15% in urine and 6% in feces). The rest is broken down extensively by liver enzymes into dozens of inactive fragments before being excreted. Researchers have identified at least 38 distinct breakdown products in urine and 20 in feces.
Because the liver does most of the heavy lifting in processing Lynparza, anything that affects liver enzyme activity can change how quickly the drug clears. Lynparza is primarily processed by the same liver enzyme family responsible for breaking down grapefruit-interacting medications. Taking strong inhibitors of that enzyme (certain antifungals, some antibiotics, and grapefruit juice in large amounts) can slow clearance and raise drug levels in your blood. On the flip side, strong enzyme inducers like certain seizure medications or St. John’s wort can speed up clearance and reduce the drug’s effectiveness.
Factors That Slow Clearance
Kidney and liver function are the two biggest variables that determine whether Lynparza lingers longer than average in your system.
For liver impairment, clinical trials found reassuring results. Patients with mild liver impairment had only about a 15% increase in drug exposure compared to patients with normal liver function, and those with moderate impairment showed roughly an 8% increase. Neither change was considered clinically meaningful, and no dose adjustments are needed for mild or moderate liver impairment.
Kidney function tells a slightly different story. Mild kidney impairment causes a small, insignificant increase in drug levels. But moderate kidney impairment raises drug exposure by about 44%, which is enough to matter. Patients in that category may need a lower dose and closer monitoring, both of which affect how much drug is circulating at any given time.
Why the Safety Windows Are Longer Than 7 Days
If Lynparza is essentially cleared within a week, you might wonder why official safety guidelines extend much further. The answer is that trace drug levels and the biological effects of Lynparza on cells can outlast the detectable presence of the drug itself. Lynparza works by blocking a DNA repair enzyme inside cells, and the consequences of that interference, particularly on reproductive cells, persist well beyond the point when blood levels hit zero.
The FDA prescribing information reflects this with three distinct timelines:
- Breastfeeding: Do not breastfeed during treatment or for one month after the final dose.
- Contraception for women: Use effective contraception during treatment and for six months after the last dose.
- Contraception for men: Use effective contraception during treatment and for three months after the last dose, based on findings from genetic toxicity and animal reproduction studies.
These windows are not about the drug still being present in your bloodstream. They account for the time needed for affected cells, especially eggs and sperm, to fully turn over and recover from any DNA damage the drug may have caused.
Practical Timeline After Your Last Dose
Here is a rough guide to what happens after you stop taking Lynparza. Within 24 hours, blood levels drop to about 25% of their peak (two half-lives). By 48 to 60 hours, levels fall below 10% of peak, and most people would have negligible active drug circulating. By 7 days, essentially all of the drug and its metabolites have been excreted through urine and feces.
If you have normal kidney and liver function, clearance follows this standard timeline closely. If you have moderate kidney impairment, expect the process to take somewhat longer since the drug accumulates to higher levels during treatment and takes proportionally more time to wash out. Your oncologist can give you a more personalized estimate based on your lab values and how long you were on the medication.